|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net income | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Allocated expense for warrant issuance cost | |
| Interest reinvested in the Trust Account | |
| Loss from change in fair value of public warrant liabilities | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Accrued expenses, formation and offering costs | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Cash deposited in Trust Account | |
| Cash withdrawn from Trust Account as tax and regulatory withdrawal | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Proceeds from sale of Units in initial public offering | |
| Proceeds from sale of Private Placement Shares to Sponsor | |
| Change in deferred offering costs | |
| Payment of underwriter's discounts and commissions | |
| Proceeds from notes payable – related party | |
| Repayment of notes payable - related party | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash at beginning of year | |
| Cash at end of year | |
| Supplemental disclosure of non-cash financing activities: | |
| Offering costs included in accrued expenses | |
| Advisory fee | |
| Deferred underwriting compensation | |
| Offering costs charged to additional paid in capital | |
| Initial classification of warrant liability - public |
Loading...
